Radiology in pleural disease: State of the art

Respirology

Volumn 9, Issue 3, 2004, Pages 300-312

  Evans, Amlyn L ^a   Gleeson, Fergus V ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Magnetic resonance imaging; Pleural diseases; Radiology; Ultrasonography; X ray computed tomography

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; INTERVENTIONAL RADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; THORAX RADIOGRAPHY;

EMPYEMA, PLEURAL; HUMANS; MAGNETIC RESONANCE IMAGING; MESOTHELIOMA; PLEURA; PLEURAL DISEASES; PLEURAL EFFUSION; PNEUMOTHORAX; POSITRON-EMISSION TOMOGRAPHY; PUNCTURES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 6044226674     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2004.00599.x     Document Type: Review

References (114)

1. Moskowitz H, Platt RT, Schachar R, Mellins H. Roentgen visualization of minute pleural effusion. An experimental study to determine the minimum amount of pleural fluid visible on a radiograph. Radiology 1973; 109: 33-5.
2. Carr JJ, Reed JC, Choplin RH, Pope TL Jr, Case LD. Plain and computed radiography for detecting experimentally induced pneumothorax in cadavers: implications for detection in patients. Radiology 1992; 183: 193-9.
3. Patel MC, Flower CD. Radiology in the management of pleural disease. Eur. Radiol. 1997; 7: 1454-62.
4. Koh D-M, Burke S, Davies N, Padley SPG. Transthoracic US of the chest: Clinical uses and applications. Radiographics [Serial online] 2002; 22: 1e. [Cited 29 February 2004.] Available from URL: http://radiographics.rsnajnls.org/ cgi/content/(Abstract)/22/1/e1
5. Wernecke K. Sonographic features of pleural disease. AJR Am. J. Roentgenol. 1997; 168: 1061-6.
6. McLoud TC, Flower CD. Imaging the pleura: sonography, CT, and MR imaging. AJR Am. J. Roentgenol. 1991; 156: 1145-53.
7. Lichtenstein DA, Menu Y. A bedside ultrasound sign ruling out pneumothorax in the critically ill. Lung sliding. Chest 1995; 108: 1345-8.
8. Goodman TR, Traill ZC, Phillips AJ, Berger J, Gleeson FV. Ultrasound detection of pneumothorax. Clin. Radiol. 1999; 54: 736-9.
9. Chang DB, Yang PC, Luh KT, Kuo SH, Yu CJ. Ultrasound-guided pleural biopsy with Tru-Cut needle. Chest 1991; 100: 1328-33.
10. Adams RF, Gleeson FV. Percutaneous image-guided cutting-needle biopsy of the pleura in the presence of a suspected malignant effusion. Radiology 2001; 219: 510-14.
11. Aberle DR, Gamsu G, Ray CS. High-resolution CT of benign asbestos-related diseases: clinical and radiographic correlation. AJR Am. J. Roentgenol. 1988; 151: 883-91.
12. Mastora I, Amara A, Remy J, Remy-Jardin ML, Sebban N, Sobaszek A. Screening for asbestos related pleuropulmonary disorders with low dose multislice spiral CT. In: Proceedings of the Radiological Society of North America 88th Scientific Assembly and Annual Meeting; 1-6 Dec 2002. Radiological Society of North America, Chicago, IL, 2002; 235.
13. Fishman EK, Jeffrey RB. Spiral CT: Principles, Techniques, and Clinical Applications, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, PA, 1998.
14. Knisely BL, Kuhlman JE. Radiographic and computed tomography (CT) imaging of complex pleural disease. Crit. Rev. Diagn. Imaging 1997; 38: 1-58.
15. Webb WR, Müller NL, Naidich DP. High-Resolution CT of the Lung, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, PA, 2001.
16. Im JG, Webb WR, Rosen A, Gamsu G. Costal pleura: appearances at high-resolution CT. Radiology 1989; 171: 125-31.
17. Knisely BL, Broderick LS, Kuhlman JE. MR imaging of the pleura and chest wall. Magn. Reson. Imaging Clin. N. Am. 2000; 8: 125-41.
18. White CS. Magnetic resonance imaging of the chest. Respir. Care 2001; 46: 922-31.
19. McLoud TC. CT and MR in pleural disease. Clin. Chest Med. 1998; 19: 261-76.
20. Goldsmith SJ, Kostakoglu L. Nuclear medicine imaging of lung cancer. Radiol. Clin. North Am. 2000; 38; 511-24.
21. Blackmore CC, Black WC, Dallas RV, Crow HC. Pleural fluid volume estimation: a chest radiograph prediction rule. Acad. Radiol 1996; 3: 103-9.
22. Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions. J. Clin. Ultrasound 2003; 31: 69-74.
23. Henschke CI, Davis SD, Romano PM, Yankelevitz DF. Pleural effusions, pathogenesis, radiologic evaluation, and therapy. J. Thorac. Imaging 1989; 4: 49-60.
24. Liberson M. Diagnostic significance of the mediastinal profile in massive unilateral pleural effusions. Am. Rev. Respir. Dis. 1963; 88: 176-80.
25. Mulvey RB. The effect of pleural fluid on the diaphragm. Radiology 1965; 84: 1080-86.
26. Müller NL. Imaging of the pleura. Radiology 1993; 186: 297-309.
27. Schwarz MI, Marmorstein BL. A new radiologic sign of subpulmonic effusion. Chest 1975; 67: 176-8.
28. Hanna JW, Reed JC, Choplin RH. Pleural infections: a clinical-radiologic review. J. Thorac. Imaging 1991; 6: 68-79.
29. Lomas DJ, Padley SG, Flower CD. The sonographic appearances of pleural fluid. Br. J. Radiol. 1993; 66: 619-24.
30. Yang PC, Luh KT, Chang DB, Wu HD, Yu CJ, Kuo SH. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am. J. Roentgenol. 1992; 159: 29-33.
31. Kearney SE, Davies CW, Davies RJ, Gleeson FV. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin. Radiol. 2000; 55: 542-7.
32. Bressler EL, Francis IR, Glazer GM, Gross BH. Bolus contrast medium enhancement for distinguishing pleural from parenchymal lung disease: CT features. J. Comput. Assist. Tomogr. 1987; 11: 436-40.
33. Waite RJ, Carbonneau RJ, Balikian JP, Umali CB, Pezzella AT, Nash G. Parietal pleural changes in empyema: appearances at CT. Radiology 1990; 175: 145-50.
34. Davies C, Gleeson FV. Diagnostic radiology. In: Light RW, Lee YCG (eds). Textbook of Pleural Diseases. Arnold, London, 2003; 210-37.
35. Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am. J. Roentgenol. 1990; 154: 487-92.
36. Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin. Radiol. 2001; 56: 193-6.
37. Tscholakoff D, Sechtem U, de Geer G, Schmidt H, Higgins CB. Evaluation of pleural and pericardial effusions by magnetic resonance imaging. Eur. J. Radiol. 1987; 7: 169-74.
38. Davis SD, Henschke CI, Yankelevitz DF, Cahill PT, Yi Y. MR imaging of pleural effusions. J. Comput. Assist. Tomogr. 1990; 14: 192-8.
39. Baysal T, Bulut T, Gökirmak M, Kalkan S, Dusak A, Dogan M. Diffusion-weighted MR imaging of pleural fluid: differentiation of transudative vs exudative pleural effusions. Eur. Radiol. 2004; 14: 890-6.
40. Bury T, Paulus P, Dowlati A, Corhay JL, Rigo P, Radermecker MF. Evaluation of pleural diseases with FDG-PET imaging: preliminary report. Thorax 1997; 52: 187-9.
41. Duysinx B, Nguyen D, Louis R et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest 2004; 125: 489-93.
42. Schramel FM, Golding RP, Haakman CD, Sutedja TG, de Jong KA, Postmus PE. Expiratory chest radiographs do not improve visibility of small apical pneumothoraces by enhanced contrast. Eur. Respir. J. 1996; 9: 406-9.
43. Glazer HS, Anderson DJ, Wilson BS, Molina PL, Sagel SS. Pneumothorax: appearance on lateral chest radiographs. Radiology 1989; 173: 707-11.
44. Bourgouin P, Cousineau G, Lemire P, Hebert G. Computed tomography used to exclude pneumothorax in bullous lung disease. J. Can. Assoc. Radiol. 1985; 36: 341-2.
45. Tocino IM, Miller MH, Fairfax WR. Distribution of pneumothorax in the supine and semirecumbent critically ill adult. AJR Am. J. Roentgenol. 1985; 144: 901-5.
46. Gordon R. The deep sulcus sign. Radiology 1980; 136: 25-7.
47. Rowan KR, Kirkpatrick AW, Liu D, Forkheim KE, Mayo JR, Nicolaou S. Traumatic pneumothorax detection with thoracic US: correlation with chest radiography and CT-initial experience. Radiology 2002; 225: 210-14.
48. Sistrom CL, Reiheld CT, Gay SB, Wallace KK. Detection and estimation of the volume of pneumothorax using real-time sonography: efficacy determined by receiver operating characteristic analysis. AJR Am. J. Roentgenol. 1996; 166: 317-21.
49. Bungay HK, Berger J, Traill ZC, Gleeson FV. Pneumothorax post CT-guided lung biopsy, a comparison between detection on chest radiographs and CT. Br. J. Radiol. 1999; 72: 1160-63.
50. Tocino IM, Miller MH. Computed tomography in blunt chest trauma. J. Thorac. Imaging 1987; 2: 45-59.
51. Schwartz DA, Fuortes LJ, Galvin JR et al. Asbestos-induced pleural fibrosis and impaired lung function. Am. Rev. Respir. Dis. 1990; 141: 321-6.
52. Schwartz DA. New developments in asbestos-induced pleural disease. Chest 1991; 99: 191-8.
53. Rockoff SD, Kagan E, Schwartz A, Kriebel D, Hix W, Rohatgi P. Visceral pleural thickening in asbestos exposure: the occurrence and implications of thickened interlobar fissures. J. Thorac. Imaging 1987; 2: 58-66.
54. Proto AV. Conventional chest radiographs: anatomic understanding of newer observations. Radiology 1992; 183: 593-603.
55. Staples CA. Computed tomography in the evaluation of benign asbestos-related disorders. Radiol. Clin. North Am. 1992; 30: 1191-207.
56. Gefter WB, Epstein DM, Miller WT. Radiographic evaluation of asbestos-related chest disorders. Crit. Rev. Diagn. Imaging 1984; 21: 133-81.
57. Roach HD, Davies GJ, Attanoos R, Crane M, Adams H, Phillips S. Asbestos: when the dust settles-an imaging review of asbestos-related disease. Radiographics 2002; 22: S167-84.
58. Theros EG, Feigin DS. Pleural tumors and pulmonary tumors: differential diagnosis. Semin. Roentgenol. 1977; 12: 239-47.
59. 2. Migratory chest mass. Invest. Radiol. 1990; 25: 209-11.
60. Dedrick CG, McLoud TC, Shepard JA, Shipley RT. Computed tomography of localized pleural mesothelioma. AJR Am. J. Roentgenol. 1985; 144: 275-80.
61. Mendelson DS, Meary E, Buy JN, Pigeau I, Kirschner PA. Localized fibrous pleural mesothelioma: CT findings. Clin. Imaging 1991; 15: 105-8.
62. Saifuddin A, Da Costa P, Chalmers AG, Carey BM, Robertson RJ. Primary malignant localized fibrous tumours of the pleura: clinical, radiological and pathological features. Clin. Radiol. 1992; 45: 13-17.
63. Tateishi U, Nishihara H, Morikawa T, Miyasaka K. Solitary fibrous tumor of the pleura: MR appearance and enhancement pattern. J. Comput. Assist. Tomogr. 2002; 26: 174-9.
64. McLoud TC, Woods BO, Carrington CB, Epler GR, Gaensler EA. Diffuse pleural thickening in an asbestos-exposed population: prevalence and causes. AJR Am. J. Roentgenol. 1985; 144: 9-18.
65. Lynch DA, Gamsu G, Aberle DR. Conventional and high resolution computed tomography in the diagnosis of asbestos-related diseases. Radiographics 1989; 9: 523-51.
66. McLoud TC. The use of CT in the examination of asbestos-exposed persons. Radiology 1988; 169: 862-3.
67. Wu RG, Yang PC, Kuo SH, Luh KT. 'Fluid color' sign: a useful indicator for discrimination between pleural thickening and pleural effusion. J. Ultrasound Med. 1995; 14: 767-9.
68. Copley SJ, Wells AU, Rubens MB et al. Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology 2001; 220: 237-43.
69. Henschke CI, Yankelevitz DF, Davis SD. Pleural diseases: multimodality imaging and clinical management. Curr. Probl. Diagn. Radiol. 1991; 20: 155-81.
70. Dynes MC, White EM, Fry WA, Ghahremani GG. Imaging manifestations of pleural tumors. Radiographics 1992; 12: 1191-201.
71. Hoffmann U, Globits S, Schima W et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am. J. Cardiol. 2003; 92: 890-95.
72. Luo L, Hierholzer J, Bittner RC, Chen J, Huang L. Magnetic resonance imaging in distinguishing malignant from benign pleural disease. Chin. Med. J. (Engl.) 2001; 114: 645-9.
73. Hierholzer J, Luo L, Bittner RC et al. MRI and CT in the differential diagnosis of pleural disease. Chest 2000; 118: 604-9.
74. Falaschi F, Battolla L, Mascalchi M et al. Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am. J. Roentgenol. 1996; 166: 963-8.
75. Lorigan JG, Libshitz HI. MR imaging of malignant pleural mesothelioma. J. Comput. Assist. Tomogr. 1989; 13: 617-20.
76. Gupta NC, Rogers JS, Graeber GM et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 2002; 122: 1918-24.
77. Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF. FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am. J. Roentgenol. 2000; 175: 245-9.
78. Weiss N, Solomon SB. Talc pleurodesis mimics pleural metastases: differentiation with positron emission tomography/computed tomography. Clin. Nucl. Med. 2003; 28: 811-14.
79. Lowe VJ, Hebert ME, Anscher MS, Coleman RE. Serial evaluation of increased chest wall F-18 fluorodeoxyglucose (FDG) uptake following radiation therapy in patients with bronchogenic carcinoma. Clin. Positron Imaging 1998; 1: 185-91.
80. Carretta A, Landoni C, Melloni G et al. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases-a pilot study. Eur. J. Cardiothorac. Surg. 2000; 17: 377-83.
81. Goswami GK, Jana S, Santiago JF et al. Discrepancy between Ga-67 citrate and F-18 fluorodeoxyglucose positron emission tomographic scans in pulmonary infection. Clin. Nucl. Med. 2000; 25: 490-91.
82. Pisani RJ, Colby TV, Williams DE. Malignant mesothelioma of the pleura. Mayo Clin. Proc. 1988; 63: 1234-44.
83. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345: 535-9.
84. Miller BH, Rosado-de-Christenson ML, Mason AC, Fleming MV, White CC, Krasna MJ. From the archives of the AFIP. Malignant pleural mesothelioma: radiologic-pathologic correlation. Radiographics 1996; 16: 613-44.
85. Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am. J. Roentgenol. 1990; 155: 965-9.
86. Ng CS, Munden RF, Libshitz HI. Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases. Clin. Radiol. 1999; 54: 415-21.
87. Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J. Nucl. Med. 1999; 40: 1241-5.
88. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 2003; 126: 11-16.
89. 18F-fluorodeoxyglucose and PET. Comparison with computed tomography. Clin. Positron Imaging 2000; 3: 165.
90. 18F-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 2000; 120: 128-33.
91. 18F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J. Nucl. Med. 2002; 43: 1144-9.
92. Wang ZJ, Reddy GP, Gotway MB et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 2004; 24: 105-19.
93. Ng DC, Hain SF, O'Doherty MJ, Dussek J. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J. Nucl. Med. 2000; 41: 1443-4.
94. Kohan JM, Poe RH, Israel RH et al. Value of chest ultrasonography versus decubitus roentgenography for thoracentesis. Am. Rev. Respir. Dis. 1986; 133: 1124-6.
95. Klein JS, Schultz S, Heffner JE. Interventional radiology of the chest: image-guided percutaneous drainage of pleural effusions, lung abscess, and pneumothorax. AJR Am. J. Roentgenol. 1995; 164: 581-8.
96. Rosenberg ER. Ultrasound in the assessment of pleural densities. Chest 1983; 84: 283-5.
97. Harnsberger HR, Lee TG, Mukuno DH. Rapid, inexpensive real-time directed thoracentesis. Radiology 1983; 146: 545-6.
98. Raptopoulos V, Davis LM, Lee G, Umali C, Lew R., Irwin RS. Factors affecting the development of pneumothorax associated with thoracentesis. AJR Am. J. Roentgenol. 1991; 156: 917-20.
99. Jones PW, Moyers JP, Rogers JT, Rodriguez RM, Lee YC, Light RW. Ultrasound-guided thoracentesis: is it a safer method? Chest 2003; 123: 418-23.
100. Hyde J, Sykes T, Graham T. Reducing morbidity from chest drains. BMJ 1997; 314: 914-15.
101. Clementsen P, Evald T, Grode G, Hansen M, Krag Jacobsen G, Faurschou P. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir. Med. 1998; 92: 593-6.
102. Taylor PM. Catheters smaller than 24 French gauge can be used for chest drains. BMJ 1997; 315: 186.
103. Patz EF Jr, Goodman PC, Erasmus JJ. Percutaneous drainage of pleural collections. J. Thorac. Imaging 1998; 13: 83-92.
104. Tattersall DJ, Traill ZC, Gleeson FV. Chest drains: does size matter? Clin. Radiol. 2000; 55: 415-21.
105. Conces DJ Jr, Tarver RD, Gray WC, Pearcy EA. Treatment of pneumothoraces utilizing small caliber chest tubes. Chest 1988; 94: 55-7.
106. Parry GW, Morgan WE, Salama FD. Management of haemothorax. Ann. R. Coll. Surg. Engl. 1996; 78: 325-6.
107. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106: 1215-22.
108. Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003; 361: 1326-30.
109. Perkins GD, Thickett D. CT-guided biopsy for diagnosis of malignant disease in pleural effusions. Lancet 2003; 362: 173.
110. Scott EM, Marshall TJ, Flower CD, Stewart S. Diffuse pleural thickening: percutaneous CT-guided cutting needle biopsy. Radiology 1995; 194: 867-70.
111. Screaton NJ, Flower CD. Percutaneous needle biopsy of the pleura. Radiol. Clin. North Am. 2000; 38: 293-301.
112. Metintas M, Özdemir N, Isiksoy S et al. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma. J. Comput. Assist. Tomogr. 1995; 19: 370-74.
113. Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993; 72: 389-93.
114. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995; 108: 754-8.